Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review

The objective of this study was to critically review the cost-effectiveness (CE) of the recombinant zoster vaccine (RZV) against herpes zoster (HZ). A literature review was conducted in PubMed, Embase, and Cochrane between January 1, 2017, and February 28, 2022, and on select public healthcare agenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Giannelos, Nikolaos, Ng, Cheryl, Curran, Desmond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Zoster
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054181/
https://www.ncbi.nlm.nih.gov/pubmed/36916240
http://dx.doi.org/10.1080/21645515.2023.2168952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054181/
https://www.ncbi.nlm.nih.gov/pubmed/36916240
http://dx.doi.org/10.1080/21645515.2023.2168952

Ejemplares similares